Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 29;120(35):e2312272120.
doi: 10.1073/pnas.2312272120. Epub 2023 Aug 22.

Improved evidence to guide dementia care is urgently needed

Andrew N March  1 , Clare Stroud  1 , Eric B Larson  2
Affiliations
Editorial

Improved evidence to guide dementia care is urgently needed

Andrew N March et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

E.B.L. chaired the Committee on Care Interventions for Individuals with Dementia and their Caregivers. C.S. and A.N.M. served as National Academies staff that supported the committee and the development of their report.

Figures

Fig. 1.
Fig. 1.
Framework of dementia care interventions. Reprinted with permission from ref. .
See this image and copyright information in PMC

References

    1. U.S. Food and Drug Administration, FDA grants accelerated approval for Alzheimer’s drug (U.S. Food and Drug Administration, 2021)
    1. U.S. Food and Drug Administration, FDA grants accelerated approval for Alzheimer’s disease treatment (U.S. Food and Drug Administration, 2023).
    1. Eli Lilly and Company, Lilly’s Donanemab significantly slowed cognitive and functional decline in phase 3 study of early Alzheimer’s disease (Eli Lilly and Company, 2023).
    1. Atwood C. S., Perry G., Playing Russian Roulette with Alzheimer’s disease patients: Do the cognitive benefits of lecanemab outweigh the risk of edema, stroke and encephalitis? J. Alzheimers Dis. 92, 799–801 (2023). - PubMed
    1. Karlawish J., Aducanumab and the business of Alzheimer disease—some choice. JAMA Neurol. 78, 1303–1304 (2021). - PubMed

Publication types